Back to Search Start Over

Supplemental Figure 1 from An Oral Formulation of YK-4-279: Preclinical Efficacy and Acquired Resistance Patterns in Ewing Sarcoma

Authors :
Joseph A. Ludwig
James E. O'Dorisio
Kirk S. Culotta
Dannette K. Doolittle
Adrianna S. Buford
Rebecca L. Maywald
Ramani A. Aiyer
Vandhana Ramamoorthy
Brian A. Menegaz
Salah-Eddine Lamhamedi-Cherradi
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

Supplemental Figure 1. Gene expression changes between sensitive and YK-resistant ES cell lines

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....6d7a91dbda7625f7135e74ca477cb93f